Tripartite intensive intervention for prevention of rebleeding in elderly patients with hypertensive cerebral hemorrhage

doi:10.12998/wjcc.v9.i33.10106

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 33

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3520)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-7) series.

Item

Count

PDF

227

WORD

HTML

2133

Tables (1-7)

300

Sum=2754

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

262

Download

504

Sum=766

Nov 26, 2021 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Nov 26, 2021; 9(33): 10106-10115
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10106

Table 1 General participant characteristics in the two groups, n (%)

Parameters	Control group, n = 75	Observation group, n = 75	χ²/t	P value
Sex			0.107	0.744
Male	40 (53.33)	38 (50.67)
Female	35 (46.67)	37 (49.33)
Age in yr	67.96 ± 6.11	68.45 ± 5.89	0.500	0.618
Hypertension course in yr	8.56 ± 2.17	8.41 ± 2.23	0.417	0.677
Time of onset in h	6.45 ± 2.13	6.51 ± 2.28	0.167	0.868
Bleeding in mL	36.58 ± 5.45	37.12 ± 5.08	0.628	0.531
Cerebral hemorrhage site			1.841	0.398
Basal ganglia	48 (64.00)	41 (54.67)
The hypothalamus	19 (25.33)	21 (28.00)
Cerebral lobe	8 (10.67)	13 (17.33)
Level of education			0.435	0.805
Primary or lower secondary	12 (16.00)	11 (14.67)
High school, or secondary school,	38 (50.67)	42 (56.00)
College or above	25 (33.33)	22 (29.33)
Combined diseases
Chronic obstructive pulmonary disease	27 (36.00)	33 (44.00)	1.000	0.317
Coronary heart disease	22 (29.33)	15 (20.00)	1.758	0.185
Diabetes	16 (21.33)	20 (26.67)	0.585	0.444
Hyperlipidemia	36 (48.00)	38 (50.67)	0.107	0.744

Table 2 Hospital stay, cost, and rebleeding rate in the two groups

Group	Number of cases	Hospital stay in d	Hospitalization costs, 10000 yuan	Rebleeding rate during hospitalization, n (%)
Control group	75	16.89 ± 2.45	2.76 ± 0.32	10 (13.33)
Observation Group	75	15.21 ± 2.34	2.58 ± 0.28	3 (4.00)
t/χ²		2.294	3.666	4.127
P value		0.000	0.000	0.042

Table 3 Cerebral blood flow indexes in the two groups (mean ± SD)

Group	Number of cases	Q_mean in mL/s		V_mean in cm/s		Dynamic resistance in kPa·s/m		Peripheral vascular resistance in kPa·s/m
Group	Number of cases	Pre-intervention	After intervention	Pre-intervention	After intervention	Pre-intervention	After intervention	Pre-intervention	After intervention
Control group	75	8.64 ± 0.64	10.35 ± 0.71^a	12.52 ± 1.36	16.36 ± 1.42^a	461.58 ± 51.33	351.23 ± 42.02^a	1896.35 ± 315.23	912.36 ± 102.05^a
Observation Group	75	8.69 ± 0.72	11.56 ± 0.57^a	12.43 ± 1.82	18.21 ± 1.53^a	452.87 ± 56.74	323.52 ± 28.47^a	1904.27 ± 286.89	854.23 ± 84.56^a
t		0.449	11.509	0.343	7.675	0.986	4.728	0.161	3.798
P value		0.654	0.000	0.732	0.000	0.326	0.000	0.872	0.000

^aP < 0.05 vs the same group before intervention.

Table 4 Health behavior scores in the two groups (mean ± SD)

Parameter	Time	Control group, n = 75	Observation group, n = 75	t	P value
Emotional control	Pre-intervention	5.74 ± 0.96	5.69 ± 1.02	0.309	0.758
	After intervention	7.32 ± 0.67^a	8.51 ± 0.88^a	9.318	0.000
Compliance with medication	Pre-intervention	7.65 ± 1.12	7.59 ± 1.08	0.334	0.739
	After intervention	12.33 ± 1.54^a	12.54 ± 1.26^a	0.914	0.362
Catering management	Pre-intervention	10.23 ± 1.35	10.08 ± 1.27	0.701	0.484
	After intervention	14.12 ± 1.24^a	16.35 ± 1.41^a	10.285	0.000
Movement management	Pre-intervention	10.45 ± 1.08	10.29 ± 1.13	0.886	0.377
	After intervention	14.03 ± 1.51^a	16.65 ± 1.32^a	11.313	0.000
Self-monitoring	Pre-intervention	6.52 ± 0.58	6.61 ± 0.67	0.880	0.381
	After intervention	7.89 ± 0.64^a	8.78 ± 0.69^a	8.190	0.000

^aP < 0.05 vs the same group before intervention.

Table 5 National Institutes of Health Stroke Scale and Quality of Life Index scores between the two groups (mean ± SD, subdivision)

Group	Number of cases	NIHSS score		QLI score
Group	Number of cases	Pre-intervention	After intervention	Pre-intervention	After intervention
Control group	75	13.23 ± 3.26	7.45 ± 2.66^a	5.65 ± 1.14	6.85 ± 1.75^a
Observation Group	75	14.02 ± 3.41	6.27 ± 2.13^a	5.58 ± 1.25	7.53 ± 1.27^a
t		1.450	2.999	0.358	2.724
P value		0.149	0.003	0.721	0.007

^aP < 0.05 vs the same group before intervention.

NIHSS: National Institutes of Health Stroke Scale; QLI: Quality of Life Index.

Table 6 Complications during hospitalization in both groups, n (%)

Group	Number of cases	Pulmonary infection	Pressure sore	Central hyperthermia	Deep venous thrombosis	Total
Control group	75	2 (2.67)	3 (4.00)	5 (6.67)	2 (2.67)	12 (16.00)
Observation group	75	0 (0.00)	1 (1.33)	2 (2.67)	0 (0.00)	3 (4.00)
χ²						6.000
P value						0.014

Table 7 Satisfaction in the two groups, n (%)

Group	Number of cases	Very pleased	Satisfactory	Not satisfied	Satisfaction rate
Control group	75	29 (38.67)	33 (44.00)	13 (17.33)	62 (82.67)
Observation group	75	42 (56.00)	28 (37.33)	5 (6.67)	70 (93.33)
χ²					4.040
P value					0.044

Citation: Li CX, Li L, Zhang JF, Zhang QH, Jin XH, Cai GJ. Tripartite intensive intervention for prevention of rebleeding in elderly patients with hypertensive cerebral hemorrhage. World J Clin Cases 2021; 9(33): 10106-10115
URL: https://www.wjgnet.com/2307-8960/full/v9/i33/10106.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i33.10106